Dengue Fever
InViragen and Shantha Biotechnics announce dengue vaccine manufacturing agreement
Published in Blood Weekly, November 30th, 2006
InViragen will use materials made under this agreement to complete preclinical studies and initiate testing of the vaccine for safety and efficacy in human volunteers.
Dengue viruses threaten over a third of the world's population and cause an estimated 100-150 million cases of dengue fever every year, according to the company. InViragen's dengue vaccine was designed by collaborators at the U.S. Centers for Disease Control & Prevention (CDC) to protect against all four of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-11-30)
More Articles from Blood Weekly
- Fibrinolysis
Research on fibrinolysis published by scientists at Academic Medical Center, Department of Surgery - Nosocomial Prevention
Tel-Aviv University, Department of Nursing reports research in nosocomial prevention - Sepsis Cell Biology
Investigators at University of Perugia, Department of Experimental Medicine and Biochemical Sciences release new data on sepsis cell biology - Acute Myeloid Leukemia
Lorus Therapeutics announces presentation on GTI-2040 uptake by tumor cells in AML - Awards
Director of DaVita's clinical education team Norma Gomez receives award from Florida ESRD Network - Awards
Medical University of South Carolina receives Abiomed Center of Excellence designation - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
